Freenome, Inc.
FRNM- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0002017526
No open-market purchases or sales by Freenome, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $95.7M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Freenome, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 34 | 27 | −7 |
| Shares | 10.1M | 8.80M | −1.32M (−13.1%) |
| Value | $111.0M | $95.7M | −$15.3M (−13.8%) |
New holders (7)
Institutions that held Freenome, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 661,493 | $7.22M | 0.25% |
| K2 Principal Fund, L.P. | 182,124 | $1.98M | 0.18% |
| Harraden Circle Investments, LLC | 35,743 | $388.9K | 0.05% |
| Citadel Advisors LLC | 16,454 | $179.0K | 0.00% |
| UBS Group AG | 3,842 | $41.8K | 0.00% |
| US Bancorp | 603 | $6.56K | 0.00% |
| Morgan Stanley | 1 | $11 | 0.00% |
Sold out (14)
Institutions that held Freenome, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| 683 Capital Management, LLC | 561,923 | $6.16M |
| Empyrean Capital Partners, LP | 282,100 | $3.09M |
| Ikarian Capital, LLC | 240,951 | $2.64M |
| Balyasny Asset Management LLC | 162,434 | $1.78M |
| Boothbay Fund Management, LLC | 161,437 | $1.77M |
| DLD Asset Management, LP | 126,083 | $1.38M |
| LMR Partners LLP | 117,421 | $1.29M |
| Lineage Point Capital LP | 80,258 | $880.4K |
| Longaeva Partners L.P. | 36,614 | $401.7K |
| J. Goldman & Co LP | 31,428 | $344.8K |
| Virtu Financial LLC | 23,234 | $255.0K |
| Schonfeld Strategic Advisors LLC | 15,030 | $164.9K |
| Readystate Asset Management LP | 10,987 | $120.5K |
| Allworth Financial LP | 300 | $3.29K |